<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001856'>Myocarditis</z:mp> is defined as <z:mp ids='MP_0001845'>inflammation</z:mp> of the myocardium accompanied by myocellular <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:mp ids='MP_0001856'>myocarditis</z:mp> must be considered in patients who present with recent-<z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> or <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Fulminant <z:mp ids='MP_0001856'>myocarditis</z:mp> is a distinct entity characterized by sudden <z:hpo ids='HP_0003674'>onset</z:hpo> of severe <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> or cardiogenic shock, usually following a <z:e sem="disease" ids="C0521839" disease_type="Disease or Syndrome" abbrv="">flu-like illness</z:e>, parvovirus B19, human herpesvirus 6, coxsackievirus and adenovirus being the most frequently viruses responsible for the disease </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment of <z:mp ids='MP_0001856'>myocarditis</z:mp> remains largely supportive, since immunosuppression has not been proven to be beneficial for <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:mp ids='MP_0001856'>myocarditis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Trials of antiviral therapies, or immunostimulants such as interferons, suggest a potential therapeutic role but require further investigation </plain></SENT>
<SENT sid="5" pm="."><plain>Lastly, early recognition of patients rapidly progressing to refractory <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> and their immediate transfer to a medical-surgical center experienced in mechanical circulatory support is warranted </plain></SENT>
<SENT sid="6" pm="."><plain>In this setting, ECMO should be the first-line mechanical assistance </plain></SENT>
<SENT sid="7" pm="."><plain>For highly unstable patients, a Mobile Cardiac Assistance Unit, that rapidly travels to primary care hospitals with a portable ECMO system and hooks it up before refractory multiorgan failure takes hold, is the preferred option </plain></SENT>
</text></document>